C
Cantonbio
Canton Biologics provides end‑to‑end contract development and manufacturing services for monoclonal antibodies, bispecific antibodies, fusion proteins, and recombinant proteins. Its portfolio includes cell line and process development platforms, GMP‑compliant manufacturing, and comprehensive quality and regulatory support. The company leverages high‑titer CHO and microbial expression systems to accelerate IND and commercial product timelines for global biopharma clients.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Canton Biologics provides end‑to‑end contract development and manufacturing services for monoclonal antibodies, bispecific antibodies, fusion proteins, and recombinant proteins. Its portfolio includes cell line and process development platforms, GMP‑compliant manufacturing, and comprehensive quality and regulatory support. The company leverages high‑titer CHO and microbial expression systems to accelerate IND and commercial product timelines for global biopharma clients.